X4 Pharmaceuticals (XFOR) Cash from Investing Activities (2017 - 2025)
X4 Pharmaceuticals posted quarterly Cash from Investing Activities of $16.8 million for Q4 2025, up 295.44% year-on-year from $4.3 million in Q4 2024, and up 158.77% on a QoQ basis from -$28.7 million in Q3 2025.
X4 Pharmaceuticals (XFOR) has 9 years of Cash from Investing Activities data on file, last reported at $16.8 million in Q4 2025.
- For the quarter ending Q4 2025, Cash from Investing Activities rose 295.44% year-over-year to $16.8 million; the trailing twelve-month figure through Dec 2025 stood at $8.2 million (down 87.83% YoY), and the FY2025 full-year result was $8.2 million, down 87.83% from the prior year.
- Cash from Investing Activities for Q4 2025 stood at $16.8 million, up from -$28.7 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $96.9 million in Q2 2024 and bottomed at -$28.7 million in Q3 2025.
- The 5-year median for Cash from Investing Activities is -$62000.0 (2021), against an average of $3.0 million.
- Peak annual rise in Cash from Investing Activities reached 2083.25% in 2024, while the deepest fall reached 59033.33% in 2024.
- A 5-year view of Cash from Investing Activities shows it stood at -$13000.0 in 2021, then sank by 161.54% to -$34000.0 in 2022, then tumbled by 14114.71% to -$4.8 million in 2023, then slumped by 78.38% to -$8.6 million in 2024, then jumped by 295.44% to $16.8 million in 2025.
- The last three Cash from Investing Activities figures came in at $16.8 million (Q4 2025), -$28.7 million (Q3 2025), and $23.1 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -25.54 Mn |
| 10 | X4 Pharmaceuticals | 182.28 Mn | 182.28 Mn | 2.20 Mn | 16.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.85 Mn |
| Dec 31, 2025 | 16.85 Mn |
| Sep 30, 2025 | -28.67 Mn |
| Sep 30, 2025 | -28.67 Mn |
| Jun 30, 2025 | 23.11 Mn |
| Jun 30, 2025 | 23.11 Mn |
| Mar 31, 2025 | -3.14 Mn |
| Mar 31, 2025 | -3.14 Mn |
| Dec 31, 2024 | -8.62 Mn |
| Dec 31, 2024 | -8.62 Mn |
| Sep 30, 2024 | -15.93 Mn |
| Sep 30, 2024 | -15.93 Mn |
| Jun 30, 2024 | 96.86 Mn |
| Jun 30, 2024 | 96.86 Mn |
| Mar 31, 2024 | -5.32 Mn |
| Mar 31, 2024 | -5.32 Mn |
| Dec 31, 2023 | -4.83 Mn |
| Dec 31, 2023 | -4.83 Mn |
| Sep 30, 2023 | -5.16 Mn |
| Sep 30, 2023 | -5.16 Mn |
| Jun 30, 2023 | -4.88 Mn |
| Jun 30, 2023 | -4.88 Mn |
| Mar 31, 2023 | -9,000.00 |
| Mar 31, 2023 | -9,000.00 |
| Dec 31, 2022 | -34,000.00 |
| Dec 31, 2022 | -34,000.00 |
| Sep 30, 2022 | -9,000.00 |
| Sep 30, 2022 | -9,000.00 |
| Jun 30, 2022 | -38,000.00 |
| Jun 30, 2022 | -38,000.00 |
| Mar 31, 2022 | -22,000.00 |
| Mar 31, 2022 | -22,000.00 |
| Dec 31, 2021 | -13,000.00 |
| Dec 31, 2021 | -13,000.00 |
| Sep 30, 2021 | -20,000.00 |
| Sep 30, 2021 | -20,000.00 |
| Jun 30, 2021 | -86,000.00 |
| Jun 30, 2021 | -86,000.00 |
| Mar 31, 2021 | -496,000.00 |
| Mar 31, 2021 | -496,000.00 |
| Dec 31, 2020 | -302,000.00 |
| Dec 31, 2020 | -302,000.00 |
| Sep 30, 2020 | -496,000.00 |
| Sep 30, 2020 | -496,000.00 |
| Jun 30, 2020 | -9,000.00 |
| Jun 30, 2020 | -9,000.00 |
| Mar 31, 2020 | -555,000.00 |
| Mar 31, 2020 | -555,000.00 |
| Dec 31, 2019 | 21,000.00 |
| Dec 31, 2019 | 21,000.00 |
| Sep 30, 2019 | 815,000.00 |
| Sep 30, 2019 | 815,000.00 |
| Jun 30, 2019 | -10,000.00 |
| Jun 30, 2019 | -10,000.00 |
| Mar 31, 2019 | 26.41 Mn |
| Mar 31, 2019 | 26.41 Mn |
| Sep 30, 2018 | 27,000.00 |
| Sep 30, 2018 | 27,000.00 |
| Dec 31, 2017 | -319,000.00 |
| Dec 31, 2017 | -319,000.00 |
| Sep 30, 2017 | -18,000.00 |
| Sep 30, 2017 | -18,000.00 |
| Jun 30, 2017 | -24,000.00 |
| Jun 30, 2017 | -24,000.00 |
| Mar 31, 2017 | -17,000.00 |
| Mar 31, 2017 | -17,000.00 |